create a nursing care plan according to NANDA with assessment (subjective and objective data nursing diagnosis with as evidence by goal planning intervention rationale and evaluation lengthly of substance abuse

Reading File

Finding Sources

Reading File

Finding Sources

I have sufficient clinical knowledge from the library and my training to construct a comprehensive, accurate NANDA nursing care plan for substance abuse. Let me now produce the full care plan.

NANDA Nursing Care Plan: Substance Abuse / Substance Use Disorder

PATIENT PROFILE (Scenario)

Patient: 34-year-old male admitted to the medical unit via the emergency department for altered mental status and agitation. History of polysubstance use (alcohol, opioids, cocaine). Reports using daily for the past 3 years.

ASSESSMENT

Subjective Data (Patient Reports)

"I can't stop shaking and I feel like I'm going to die."
"I haven't eaten anything in two days."
"I drink a fifth of whiskey every day, and I use heroin when I can get it."
"I feel sick, anxious, and I can't sleep."
"My family doesn't want anything to do with me anymore."
"I know I have a problem but I don't know how to stop."
"I feel worthless and ashamed of what I've become."
"I've tried to quit before but always go back."

Objective Data (Nurse Observes/Measures)

Diaphoresis present; skin cool and clammy
Coarse bilateral hand tremors
Blood pressure: 158/96 mmHg; Heart rate: 108 bpm; Respiratory rate: 22/min; Temperature: 37.9 °C; SpO2: 96% on room air
Pupils: 2 mm bilaterally (miosis - consistent with opioid use); reactive
Glasgow Coma Scale: 14 (slight confusion)
CIWA-Ar score: 18 (moderate-to-severe alcohol withdrawal)
Weight: 62 kg; BMI: 19.8 (underweight)
Albumin: 2.8 g/dL (low); Total protein: 5.9 g/dL (low)
CBC: Hemoglobin 10.2 g/dL (anemia); MCV elevated (macrocytosis)
LFTs: AST 98 U/L, ALT 72 U/L (elevated)
Toxicology screen: positive for alcohol, opiates, benzodiazepines (prior prescription)
Urine output decreased; mucous membranes dry
Multiple venipuncture track marks on bilateral antecubital fossa
Anxiety, restlessness, hyperreflexia noted on exam
Patient is unkempt; reports homelessness for past 4 months
Affect: flat; avoids eye contact; minimal spontaneous speech
Reports auditory hallucinations ("hearing voices") - currently present
No current suicidal ideation; past suicide attempt reported 1 year ago

NURSING DIAGNOSES (NANDA-I) WITH CARE PLANS

NURSING DIAGNOSIS #1

Ineffective Denial related to inability to acknowledge the impact of substance use on health and relationships as evidenced by patient minimizing substance use history, continuing use despite adverse consequences, and verbalizing belief that he "can stop anytime."

Goal / Expected Outcome: By discharge (or within 72 hours), the patient will verbalize acknowledgment of his substance use disorder, identify at least two negative consequences of continued use, and express willingness to participate in a structured treatment program.

Nursing Interventions & Rationale:

Intervention	Rationale
Establish a therapeutic, non-judgmental nurse-patient relationship. Maintain a calm, empathetic tone and avoid confrontational language.	Trust is foundational before any behavior change is possible. Confrontation increases defensiveness and deepens denial (Kaplan & Sadock's Comprehensive Textbook of Psychiatry).
Use motivational interviewing (MI) techniques - ask open-ended questions, reflect, affirm, summarize. ("What worries you most about your drinking?")	MI is an evidence-based communication style that elicits intrinsic motivation for change. It respects patient autonomy and is more effective than directive counseling in SUD.
Provide factual, non-threatening education about the disease model of addiction - that addiction is a chronic brain disease, not a moral failing. Use plain language.	Reframing addiction as a medical condition reduces shame and guilt that perpetuate denial, and supports engagement in treatment.
Present objective clinical findings (lab values, vital signs, withdrawal signs) in a matter-of-fact manner without shaming. Link findings directly to substance use.	Concrete physical evidence creates cognitive dissonance and may be more persuasive than emotional appeals.
Explore the patient's own values and goals (family, work, health) and collaboratively explore how substance use conflicts with those goals.	Discrepancy between personal values and current behavior is a key driver of motivation for change (stages of change model - Prochaska & DiClemente).
Document patient's stage of change (pre-contemplation, contemplation, preparation, action, maintenance) and tailor all communication accordingly.	Interventions must match the patient's readiness level to be effective. Pushing action-stage strategies on a pre-contemplator causes resistance.
Involve social work and addiction counseling services early.	Multidisciplinary approach maximizes the chance of treatment engagement.

Evaluation: Patient demonstrates movement along the transtheoretical model (ideally from pre-contemplation to contemplation). Verbalizes at least two negative consequences of his substance use. Agrees to meet with an addiction counselor before discharge. Does not refuse treatment education materials.

NURSING DIAGNOSIS #2

Risk for Injury related to CNS depression and withdrawal symptoms secondary to alcohol and polysubstance use as evidenced by CIWA-Ar score of 18, tremors, diaphoresis, elevated BP and HR, and altered mental status.

Goal / Expected Outcome: Patient will remain free from injury (falls, seizures, aspiration, self-harm) throughout hospitalization. CIWA-Ar score will decrease to below 8 within 48-72 hours with pharmacological management.

Nursing Interventions & Rationale:

Intervention	Rationale
Monitor CIWA-Ar score every 1-2 hours during acute withdrawal phase; every 4 hours once score stabilizes below 10.	Standardized scoring guides medication titration and detects deterioration early. Alcohol withdrawal can progress to life-threatening delirium tremens (DTs) if undertreated.
Administer benzodiazepines (diazepam, lorazepam, or chlordiazepoxide) per CIWA-Ar protocol as ordered.	Benzodiazepines are the first-line pharmacological treatment for alcohol withdrawal, reducing seizure risk, autonomic instability, and progression to DTs.
Place patient in a low-stimulation environment (dim lighting, quiet room, minimal interruptions).	Sensory overstimulation exacerbates agitation and can precipitate withdrawal seizures.
Keep bed in lowest position, side rails up, call light within reach; place non-slip footwear at bedside; fall-risk armband applied.	Ataxia, confusion, and tremors significantly increase fall risk during withdrawal.
Monitor vital signs every 1-2 hours (BP, HR, RR, temperature, SpO2).	Tachycardia, hypertension, and fever are markers of sympathetic overactivity in withdrawal; early detection allows timely intervention.
Maintain patent airway; have suction equipment at bedside; position patient in lateral recovery position if sedated.	Risk of aspiration is elevated in altered consciousness from combined alcohol and opioid use.
Administer thiamine (Vitamin B1) 100 mg IV/IM before any dextrose-containing IV fluids, as ordered.	Thiamine deficiency is common in chronic alcohol use; administering glucose before thiamine can precipitate Wernicke's encephalopathy - an irreversible neurological emergency.
Administer IV fluids as ordered; monitor fluid balance, electrolytes (potassium, magnesium).	Hypomagnesemia and hypokalemia lower the seizure threshold. Rehydration corrects dehydration from diaphoresis and poor intake.
Institute seizure precautions: padded side rails, oral airway at bedside, oxygen available, IV access maintained.	Alcohol withdrawal seizures peak at 24-48 hours after last drink and can occur without warning.
Monitor opioid withdrawal signs separately using the COWS (Clinical Opiate Withdrawal Scale).	Polysubstance withdrawal requires simultaneous monitoring of multiple withdrawal syndromes with different timelines and management protocols.

Evaluation: No seizures, falls, or aspiration events during hospitalization. CIWA-Ar score decreases to <8 within 48-72 hours. Vital signs return toward baseline (BP <140/90 mmHg, HR <100 bpm). Patient oriented to person, place, and time.

NURSING DIAGNOSIS #3

Imbalanced Nutrition: Less Than Body Requirements related to inadequate dietary intake, alcohol-induced malabsorption, and increased metabolic demands as evidenced by BMI 19.8, albumin 2.8 g/dL, hemoglobin 10.2 g/dL, macrocytosis, and patient report of not eating for two days.

Goal / Expected Outcome: Patient will demonstrate improved nutritional status as evidenced by consuming at least 60-70% of meals, improved albumin and hemoglobin trends within one week, and verbalization of the importance of adequate nutrition in recovery.

Nursing Interventions & Rationale:

Intervention	Rationale
Obtain a baseline nutritional assessment - weight, BMI, food preferences, history of nausea/vomiting. Consult registered dietitian.	Accurate assessment establishes baseline and guides individualized dietary plan.
Administer thiamine, folate, and multivitamin replacement as ordered.	Chronic alcohol use causes deficiency of thiamine (B1), folate, and other B-vitamins, contributing to anemia, neuropathy, and neurological dysfunction.
Offer small, frequent, high-calorie, high-protein meals and snacks. Respect food preferences when possible.	Small frequent meals are better tolerated during withdrawal due to nausea; high protein supports tissue repair and immune function.
Monitor for nausea, vomiting, and signs of gastric irritation; administer antiemetics as ordered.	Nausea and vomiting impair oral intake and can cause aspiration. Alcohol causes direct gastric mucosal irritation.
Record daily dietary intake (percentage of meals consumed). Monitor weight every 1-2 days.	Ongoing monitoring detects failure to improve and triggers escalation (e.g., enteral nutrition).
Monitor labs: albumin, total protein, CBC, electrolytes, glucose. Report abnormalities promptly.	Nutritional biomarkers trend over days-weeks; monitoring guides adequacy of supplementation and alerts to developing complications (hypoglycemia, electrolyte imbalance).
Educate patient on the relationship between nutrition and substance recovery - that alcohol is "empty calories" and displaces essential nutrients.	Health literacy supports informed decision-making and sustained behavior change post-discharge.

Evaluation: Patient consumes >60% of meals by day 3 of hospitalization. Albumin, hemoglobin, and electrolytes trend toward normal range. Patient identifies at least two nutritional changes they are willing to make in recovery.

NURSING DIAGNOSIS #4

Disturbed Sleep Pattern related to CNS stimulation during withdrawal and anxiety as evidenced by patient report of inability to sleep, restlessness, irritability, and observed agitation.

Goal / Expected Outcome: Patient will report at least 5-6 hours of uninterrupted or minimally interrupted sleep per night within 3-4 days of admission and demonstrate reduced signs of sleep deprivation (irritability, cognitive impairment).

Nursing Interventions & Rationale:

Intervention	Rationale
Assess sleep patterns using patient report and observation; document duration, quality, and disturbances.	Baseline assessment directs specific interventions and monitors improvement.
Create a sleep-promoting environment: dim lighting at night, reduce noise, maintain comfortable room temperature. Cluster nursing care activities to minimize nighttime interruptions.	Environmental modifications reduce external stimuli that fragment sleep.
Avoid caffeine-containing beverages in the evening. Offer warm non-caffeinated beverages (milk, chamomile tea).	Caffeine delays sleep onset and reduces total sleep time.
Teach relaxation techniques: deep breathing, progressive muscle relaxation, guided imagery.	Non-pharmacological approaches to anxiety reduction improve sleep quality without risk of dependence.
Administer prescribed medications for sleep/anxiety (e.g., quetiapine, trazodone, or benzodiazepines short-term during withdrawal) as ordered; monitor response and side effects.	Pharmacological support may be necessary during the acute withdrawal phase, but should be minimized to avoid substituting one dependence for another.
Educate patient that insomnia is a predictable part of early withdrawal but improves over days to weeks, and that sleep can be one of the first signs of recovery progress.	Realistic expectations reduce anxiety about insomnia, which itself worsens sleep.

Evaluation: Patient reports 5-6 hours of sleep per night by day 3-4. Decreased irritability and improved concentration documented during nursing assessment. Patient able to describe at least two sleep hygiene strategies.

NURSING DIAGNOSIS #5

Chronic Low Self-Esteem related to repeated failures to achieve sobriety, loss of family and social roles, and internalized stigma as evidenced by patient verbalizing worthlessness and shame, flat affect, avoidance of eye contact, and statements such as "I don't know how to stop."

Goal / Expected Outcome: By discharge, the patient will verbalize at least two personal strengths, identify at least one support system resource, and demonstrate beginning willingness to engage in peer support or counseling.

Nursing Interventions & Rationale:

Intervention	Rationale
Acknowledge and validate the patient's feelings of shame and guilt without reinforcing them. Use open, empathetic statements: "It sounds like you've been carrying this for a long time."	Validation de-escalates emotional distress and builds therapeutic alliance; shaming reduces engagement in care.
Consistently use person-first language ("person with a substance use disorder" rather than "addict" or "junkie"). Model this language with the entire care team.	Language shapes perception. Person-first language reduces internalized stigma and humanizes the patient experience.
Identify and verbally affirm patient strengths during each interaction (e.g., courage in seeking treatment, past resilience, relationship skills).	Cognitive reframing of strengths builds a foundation for recovery identity.
Assist patient in identifying realistic short-term goals for recovery. Encourage celebration of small milestones (e.g., completing 24 hours without substances).	Small achievable goals build self-efficacy (Bandura's theory) and counter learned helplessness associated with repeated relapse.
Provide information on peer support programs (AA, NA, SMART Recovery) and the benefit of sharing experiences with others in recovery.	Social support is one of the strongest predictors of sustained recovery; peer models normalize hope and demonstrate that recovery is possible.
Consult psychiatric-mental health nursing or social work for individual therapy referral (CBT, DBT).	Cognitive-behavioral approaches directly target the cognitive distortions and shame beliefs that underlie low self-esteem.
Involve family (with patient consent) in psychoeducation about addiction as a disease, not a choice.	Reducing family blame and increasing understanding supports reconnection, which is a major motivation for sustained sobriety.

Evaluation: Patient identifies at least two personal strengths before discharge. Agrees to attend at least one peer support group meeting. Demonstrates slight improvement in affect (smiles, increased eye contact, more spontaneous speech) by day 3-4.

NURSING DIAGNOSIS #6

Deficient Knowledge related to lack of information about substance use disorder, detoxification, and treatment options as evidenced by patient expressing confusion about why he cannot simply "stop," and asking "why am I so sick?"

Goal / Expected Outcome: Before discharge, patient will accurately describe the physiological basis of withdrawal, name at least two community treatment resources, and state a plan for next steps in recovery.

Nursing Interventions & Rationale:

Intervention	Rationale
Assess patient's current level of health literacy and readiness to learn before initiating education. Time teaching sessions when the patient is alert and not in acute withdrawal distress.	Teaching must be timed appropriately. Information given during acute withdrawal will not be retained. Assessment of literacy tailors the approach.
Teach patient about the neurobiology of addiction in simple terms: "Alcohol and opioids change the way your brain works, and stopping suddenly makes your brain react strongly - that is what causes shaking, sweating, and feeling sick."	Understanding the physiological basis of withdrawal normalizes symptoms, reduces fear, and reduces self-blame.
Provide written and verbal information about detoxification medications (what they do, why they are used, side effects).	Informed patients are more adherent and report less anxiety about treatment.
Provide a list of local and national resources: inpatient rehab, outpatient programs, SAMHSA National Helpline (1-800-662-4357), Narcotics Anonymous, Alcoholics Anonymous, SMART Recovery.	Concrete, accessible resource lists are immediately actionable and reduce barriers to follow-up.
Educate on relapse prevention strategies: identifying triggers, developing a coping plan, the role of stress in craving. Emphasize that relapse is a common part of recovery, not a failure.	Relapse prevention education reduces guilt if relapse occurs and equips the patient with practical tools.
Involve family/support person in teaching sessions if patient consents.	Family understanding improves home support and reduces the high-risk early recovery environment.
Provide discharge instructions in writing, using clear, plain language at no higher than a 6th-grade reading level.	Written instructions reinforce verbal teaching and provide a reference after discharge.

Evaluation: Patient correctly explains why he experiences withdrawal symptoms in his own words. Names at least two treatment resources before discharge. Can state one coping strategy for managing cravings. Accepts written discharge instructions.

NURSING DIAGNOSIS #7

Risk for Suicide / Self-Harm related to depression, hopelessness, and impaired judgment secondary to substance use as evidenced by history of suicide attempt 1 year ago, flat affect, verbalized worthlessness, and active substance use.

Goal / Expected Outcome: Patient will remain safe throughout hospitalization, verbalize reasons for living, and agree to a safety plan before any reduction in monitoring level.

Nursing Interventions & Rationale:

Intervention	Rationale
Perform standardized suicide risk assessment on admission and every shift (e.g., Columbia Suicide Severity Rating Scale - C-SSRS).	Structured assessment tools reliably stratify suicide risk and ensure consistent documentation. History of a prior attempt is the single strongest predictor of future attempt.
Maintain frequent 1:1 observation or Q15-minute safety checks per facility protocol based on risk level.	Close monitoring is the most direct protective intervention for a patient at elevated suicide risk.
Conduct environmental safety assessment: remove sharps, ligature risks, and any potentially harmful items from the patient's environment.	Environmental mitigation reduces means access, which is a key modifiable factor in suicide prevention.
Engage patient in a collaborative safety plan - not a "no-harm contract" (which lacks evidence) but a written personalized plan that includes warning signs, coping strategies, support contacts, and emergency contacts.	Safety planning is an evidence-based intervention associated with reduced suicidal behavior. It is active and personalized, unlike passive no-harm contracts.
Administer psychiatric medications as ordered (antidepressants, antipsychotics). Monitor for medication effect and adverse reactions.	Concurrent depression is highly prevalent in SUD; treating the comorbid mood disorder is essential for suicide risk reduction.
Consult psychiatry for formal psychiatric evaluation and co-management.	Dual-diagnosis patients (SUD + mental health) require specialized psychiatric expertise for safe management.
Build therapeutic rapport, check in with patient frequently, and communicate care and hope without being dismissive of the patient's distress.	Therapeutic relationship itself has protective value. Patients in rapport with their nurses are more likely to disclose suicidal ideation before acting on it.

Evaluation: Patient remains free from self-harm throughout hospitalization. Participates in development of a written safety plan. Denies active suicidal ideation at each assessment. Agrees to psychiatric follow-up post-discharge.

SUMMARY TABLE: NANDA DIAGNOSES AT A GLANCE

#	NANDA Nursing Diagnosis	Goal	Priority
1	Ineffective Denial	Acknowledge SUD, engage in treatment	High
2	Risk for Injury	Prevent withdrawal complications (seizures, falls)	Highest
3	Imbalanced Nutrition: Less Than Body Requirements	Improve nutritional status	High
4	Disturbed Sleep Pattern	5-6 hrs uninterrupted sleep	Moderate
5	Chronic Low Self-Esteem	Verbalize strengths, engage peer support	Moderate
6	Deficient Knowledge	Understand withdrawal, name resources	Moderate
7	Risk for Suicide/Self-Harm	Remain safe, agree to safety plan	Highest

DISCHARGE PLANNING

Referral to inpatient or intensive outpatient substance use treatment program
Psychiatric follow-up within 1 week for depression and suicide risk monitoring
Primary care follow-up within 2 weeks (LFTs, CBC, nutritional labs)
Written prescription for naltrexone (for alcohol use disorder) or buprenorphine/naloxone (for opioid use disorder) if clinically appropriate and patient consents
Narcotics Anonymous / Alcoholics Anonymous meeting schedule provided
SAMHSA hotline number given: 1-800-662-HELP (4357)
Social work referral for housing and social services
Emergency safety plan completed and copy given to patient

References: Kaplan & Sadock's Synopsis of Psychiatry; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Stahl's Essential Psychopharmacology - all available in the medical library. NANDA International Nursing Diagnoses: Definitions and Classification 2021-2023.

substance abuse alcoholism cause with rational intoxication withdrawal symptoms diagnosis measure according to DSM-5management

Finding Sources

Reading File

I now have excellent textbook content to produce a comprehensive, well-referenced answer. Here it is:

Substance Abuse: Alcoholism - Causes, Rationale, Intoxication, Withdrawal, DSM-5 Diagnosis, and Management

1. DEFINITION

Alcohol Use Disorder (AUD) - formerly "alcoholism" - is a chronic, relapsing brain disease characterized by compulsive alcohol use, loss of control over intake, and a negative emotional state when not using. Under DSM-5, it is classified on a spectrum from mild to severe based on the number of criteria met.

2. CAUSES AND RISK FACTORS (with Rationale)

2.1 Biological / Neurochemical Causes

Cause	Rationale
Genetic predisposition	Heritability of AUD is estimated at 50-60%. Twin and adoption studies confirm that genetic factors influence risk, likely through variations in alcohol metabolism enzymes (ADH, ALDH) and neurotransmitter receptor genes.
GABA receptor dysregulation	Ethanol potentiates GABA (gamma-aminobutyric acid) - the brain's main inhibitory neurotransmitter - producing sedation, anxiolysis, and euphoria. With chronic use, the brain downregulates GABA receptors, requiring more alcohol to achieve the same effect (tolerance).
NMDA glutamate receptor suppression	Ethanol blocks NMDA receptors (the main excitatory system). With chronic exposure, the brain compensates by upregulating NMDA receptors. When alcohol is removed, the unopposed excitatory surge causes withdrawal hyperactivity, seizures, and delirium tremens.
Dopamine reward pathway activation	Alcohol stimulates dopamine release in the nucleus accumbens (the brain's reward center), producing pleasure and reinforcement. This is the neurochemical basis of craving and compulsive use.
Opioid and serotonin receptor involvement	Alcohol also interacts with endogenous opioid and serotonergic receptors, contributing to its reinforcing effects and explaining why naltrexone (an opioid antagonist) reduces cravings.
Aldehyde dehydrogenase (ALDH) variant in East Asians	A genetic variation in ALDH in a significant proportion of East Asian populations leads to accumulation of toxic acetaldehyde after drinking, causing flushing, tachycardia, and nausea - acting as a natural deterrent to alcohol consumption.

2.2 Psychological Causes

Cause	Rationale
Co-occurring mental illness	Depression, bipolar disorder, PTSD, anxiety disorders, and antisocial personality disorder are strongly comorbid with AUD. Patients often use alcohol to self-medicate negative emotional states ("self-medication hypothesis").
Early trauma and adverse childhood experiences (ACEs)	Childhood abuse, neglect, or household dysfunction significantly increase the risk of later AUD through dysregulation of the stress-response system (HPA axis).
Low self-esteem and maladaptive coping	Individuals lacking effective emotional regulation skills turn to alcohol as an external coping mechanism.
Impulsivity and sensation-seeking personality traits	Associated with early initiation of drinking and higher risk of developing AUD.

2.3 Social and Environmental Causes

Cause	Rationale
Peer pressure and social norms	Social environments that normalize or glamorize heavy drinking lower inhibition against use.
Availability and affordability	Alcohol is a legal, widely marketed substance; easy access increases exposure especially among youth.
Stress and occupation	High-stress occupations (healthcare, military, hospitality) have elevated rates of AUD; alcohol is used as a stress-relief strategy.
Family environment	Growing up in a household with a parent who has AUD increases genetic risk and models alcohol as a coping strategy.
Socioeconomic factors	Poverty, unemployment, and social marginalization are associated with higher rates of heavy drinking, partly due to chronic psychosocial stress.

3. ALCOHOL METABOLISM - BRIEF RATIONALE

Alcohol (ethanol) is absorbed rapidly from the GI tract into the bloodstream and crosses the blood-brain barrier almost immediately. It is metabolized primarily in the liver by alcohol dehydrogenase (ADH) to acetaldehyde, then by aldehyde dehydrogenase (ALDH) to the harmless metabolite acetate. Women have lower gastric ADH activity, so they reach higher blood alcohol levels than men consuming equivalent amounts per kilogram body weight - explaining their greater vulnerability to alcohol-related organ damage.

4. ALCOHOL INTOXICATION

DSM-5 Diagnostic Criteria for Alcohol Intoxication (F10.x29)

All of the following must be present:

Recent ingestion of alcohol
Clinically significant maladaptive behavioral or psychological changes (e.g., inappropriate sexual or aggressive behavior, mood lability, impaired judgment) that developed during or shortly after alcohol ingestion
At least ONE of the following signs or symptoms (developing during or shortly after use):
- Slurred speech
- Incoordination (ataxia)
- Unsteady gait
- Nystagmus
- Impairment in attention or memory
- Stupor or coma
The symptoms are not attributable to another medical condition or mental disorder

Blood Alcohol Concentration (BAC) and Clinical Effects

BAC Level	Clinical Manifestations
20-30 mg/dL (0.02-0.03%)	Slowed motor performance; mildly decreased thinking ability; early mood change
30-80 mg/dL	Progressive increases in motor and cognitive impairment; mild euphoria
80-200 mg/dL	Marked incoordination; ataxia; impaired judgment; mood lability; deteriorating cognition. Legal intoxication (USA: 0.08%)
200-300 mg/dL	Nystagmus; marked slurred speech; anterograde amnesia (alcoholic "blackouts")
>300 mg/dL	Impaired vital signs; respiratory depression; coma; risk of death

Note: Tolerance significantly modifies the above. A chronic heavy drinker may show minimal signs at 150 mg/dL; absence of impairment at this level indicates significant pharmacodynamic tolerance.

Clinical Features of Acute Intoxication

Euphoria progressing to dysphoria
Disinhibition and impaired judgment
Slurred speech, ataxia, nystagmus
Nausea, vomiting
Facial flushing, tachycardia
Emotional lability, aggression
Anterograde amnesia at higher concentrations
Respiratory depression, coma (severe toxicity)

5. ALCOHOL WITHDRAWAL

Pathophysiology / Rationale

With chronic alcohol use, the brain adapts to the constant presence of a CNS depressant by:

Downregulating inhibitory GABA receptors (less inhibition available)
Upregulating excitatory NMDA glutamate receptors (more excitation available)

When alcohol is suddenly stopped, these adaptive changes are unmasked. The excitatory systems now go unopposed, producing a hyperexcitable neurological state driven by release of norepinephrine and other neurohumoral substances. This is the biological basis of all withdrawal symptoms.

Progression of Alcohol Withdrawal (Timeline)

Stage	Symptoms	Typical Onset After Last Drink
Mild	Tremulousness, anxiety, nausea, diaphoresis, tachycardia, hypertension	6-8 hours
Moderate	Perceptual disturbances (illusions, hallucinations - auditory > visual), hyperreflexia, irritability	8-24 hours
Severe	Generalized tonic-clonic seizures (withdrawal seizures)	12-48 hours (peak ~24 hr)
Life-threatening	Delirium tremens (DTs): hyperthermia, severe agitation, psychosis, dysautonomia, hemodynamic instability	Within 48-72 hours

Withdrawal phenomena usually begin within 8 hours of abstinence, peak on day 2-3, and diminish by day 4-5. However, a protracted withdrawal syndrome (mild anxiety, insomnia, dysphoria) may persist for 3-6 months and is a major trigger for relapse.

DSM-5 Diagnostic Criteria for Alcohol Withdrawal (F10.230 / F10.239)

Criterion A: Cessation or reduction in alcohol use that has been heavy and prolonged.

Criterion B: Two (or more) of the following, developing within hours to a few days after criterion A:

Autonomic hyperactivity (sweating, tachycardia >100 bpm)
Increased hand tremor
Insomnia
Nausea or vomiting
Transient visual, tactile, or auditory hallucinations/illusions
Psychomotor agitation
Anxiety
Generalized tonic-clonic seizures

Criterion C: The symptoms cause clinically significant distress or functional impairment.

Criterion D: Not attributable to another medical condition or mental disorder.

Specifier: "With perceptual disturbances" - if hallucinations with intact reality testing are present.

The Four Clinical Syndromes of Alcohol Withdrawal

Syndrome	Features	Notes
Acute uncomplicated withdrawal	Tremulousness, anxiety, nausea, diaphoresis, tachycardia, hypertension	Most common; manageable outpatient if mild
Alcoholic hallucinosis	Visual and auditory disturbances; usually illusions (patient retains reality testing); can mimic psychosis	Occurs 12-24 hr post-cessation; patient typically alert and oriented
Withdrawal seizures	Generalized tonic-clonic; often brief; may occur without other withdrawal signs	Peak 24-48 hr; may recur; medical emergency
Delirium tremens (DTs)	Severe dysautonomia (hyperthermia, tachycardia, hypertension), profound agitation, psychosis, disorientation	<5% of withdrawal cases; mortality up to 5-10% untreated; ICU-level care required

6. DSM-5 DIAGNOSTIC CRITERIA FOR ALCOHOL USE DISORDER (AUD)

DSM-5 Criteria (F10.xx) - A Problematic Pattern of Alcohol Use Manifesting as 2 or More of the Following in a 12-Month Period:

IMPAIRED CONTROL

Alcohol is often taken in larger amounts or over a longer period than intended
Persistent desire or unsuccessful efforts to cut down or control use
A great deal of time is spent obtaining, using, or recovering from alcohol
Craving - strong desire or urge to use alcohol

SOCIAL IMPAIRMENT 5. Recurrent alcohol use resulting in failure to fulfill major role obligations (work, school, home) 6. Continued use despite persistent social or interpersonal problems caused by alcohol 7. Important social, occupational, or recreational activities are given up because of alcohol

RISKY USE 8. Recurrent use in physically hazardous situations 9. Continued use despite knowledge of a persistent physical or psychological problem caused by alcohol

PHARMACOLOGICAL CRITERIA 10. Tolerance - need for increased amounts to achieve intoxication, or markedly diminished effect with same amount 11. Withdrawal - characteristic withdrawal syndrome, or alcohol (or a similar substance) is taken to relieve or avoid withdrawal symptoms

Severity Specifiers:

Severity	Number of Criteria Met
Mild AUD	2-3 symptoms
Moderate AUD	4-5 symptoms
Severe AUD	6 or more symptoms

7. DIAGNOSTIC MEASURES AND SCREENING TOOLS

Tool	Description	Scoring
AUDIT (Alcohol Use Disorders Identification Test)	10-item WHO screening questionnaire; gold standard for AUD screening	Score 8-15: hazardous use; 16-19: harmful; ≥20: dependence
CAGE Questionnaire	4 questions: Cut down, Annoyed, Guilty, Eye-opener	Score ≥2: suggests AUD; sensitivity ~60-90%
AUDIT-C	3-item brief version of AUDIT	Score ≥3 (women) or ≥4 (men): positive screen
CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol)	10-item scale assessing withdrawal severity	<8: mild; 8-15: moderate; >15: severe (pharmacotherapy indicated)
MAST (Michigan Alcoholism Screening Test)	25-item self-report questionnaire	Score ≥5 suggests AUD

Laboratory Findings Supporting AUD Diagnosis

Lab Test	Finding in AUD	Rationale
GGT (gamma-glutamyl transferase)	Elevated	Most sensitive marker for heavy alcohol use; elevated with 2-3 drinks/day
MCV (mean corpuscular volume)	Elevated (macrocytosis)	Direct toxic effect of alcohol on bone marrow erythropoiesis; folate deficiency
AST/ALT ratio	>2:1	Characteristic of alcoholic liver disease (AST:ALT >2:1 distinguishes from other liver disease)
CDT (carbohydrate-deficient transferrin)	Elevated	High specificity for heavy drinking (>4 drinks/day); persists 2-4 weeks after cessation
Blood alcohol level (BAL)	Detectable at presentation	Confirms recent use
Urine toxicology	Positive for EtG/EtS (ethyl glucuronide/sulfate)	Detects alcohol use up to 80 hours after last drink
Thiamine level	Low	Depletion from malabsorption; risk of Wernicke's encephalopathy
Electrolytes (Mg, K, PO4)	Low	Depletion from vomiting, malabsorption, and poor intake; lowers seizure threshold

8. MANAGEMENT

8.1 Acute Alcohol Intoxication Management

Intervention	Rationale
Supportive care - airway management, IV access, cardiac monitoring	No antidote for ethanol; management is supportive. Risk of aspiration and respiratory depression from CNS depression.
IV dextrose + thiamine (thiamine FIRST, then dextrose)	Prevents Wernicke's encephalopathy; glucose infusion without thiamine in a thiamine-deficient patient can acutely precipitate Wernicke's.
Fluid resuscitation	Corrects dehydration from vomiting and alcohol's diuretic effect.
Monitor blood glucose	Alcohol causes hypoglycemia by inhibiting gluconeogenesis.
Monitor for co-ingestions	Polysubstance use is common; opioids + alcohol = severe respiratory depression.
No forced "sobering"	No medication reliably reverses ethanol intoxication. Stimulants are dangerous. Time and supportive care are the only treatment.
Hemodialysis	Reserved for very severe toxicity (BAC >400-500 mg/dL with respiratory compromise).

8.2 Alcohol Withdrawal Management

Pharmacological (First-Line)

Benzodiazepines - First-line treatment for all stages of alcohol withdrawal.

Agent	Dose / Route	Notes
Diazepam (Valium)	5-20 mg PO/IV; long-acting	Preferred for most patients; long half-life provides self-tapering effect
Lorazepam (Ativan)	1-4 mg PO/IV/IM	Preferred in liver disease, elderly (no active metabolites)
Chlordiazepoxide (Librium)	25-100 mg PO	Long-acting; used for outpatient detox

Protocol-based, symptom-triggered dosing (guided by CIWA-Ar score) is superior to fixed-dose schedules. Fixed regimens lead to undertreatment or overtreatment.

Phenobarbital - Alternative or adjunct for severe withdrawal, especially benzodiazepine-refractory cases; directly activates GABA receptors.

Adjunct Medications:

Drug	Indication	Rationale
Thiamine 100 mg IV/IM	All patients (before any dextrose)	Prevents Wernicke's encephalopathy
Magnesium sulfate	Hypomagnesemia	Hypomagnesemia lowers the seizure threshold; correction reduces seizure risk
Propranolol / atenolol	Tachycardia, hypertension	Controls autonomic symptoms; does NOT prevent seizures - cannot replace benzodiazepines
Clonidine	Autonomic hyperactivity adjunct	Reduces sympathetic overactivity but does not prevent seizures
Haloperidol	Psychosis / hallucinations	Treats perceptual disturbances; does NOT prevent seizures; always combine with benzodiazepines
IV fluids + electrolytes	Dehydration, hypokalemia, hypomagnesemia	Correct metabolic derangements and reduce seizure threshold

8.3 Long-Term Management of AUD (Pharmacotherapy)

Drug	Mechanism	Evidence / Notes
Naltrexone (oral 50 mg/day or monthly injectable Vivitrol)	Opioid receptor antagonist; blocks the reward pathway that alcohol activates	First-line; reduces heavy drinking days and cravings; contraindicated with opioid use or significant hepatic impairment
Acamprosate (Campral) 666 mg TID	Modulates GABA/NMDA balance; reduces protracted withdrawal symptoms	Best for patients who have already achieved abstinence; reduces relapse; safe in liver disease
Disulfiram (Antabuse) 250-500 mg/day	Inhibits ALDH causing acetaldehyde accumulation when alcohol ingested - produces aversive reaction (flushing, nausea, vomiting, hypotension)	Poor long-term adherence; requires motivation; the Washington Manual notes current evidence suggests it is "ineffective and potentially dangerous" unless used in highly selected, supervised settings
Gabapentin 1200 mg/day (divided doses)	GABA analog; reduces cravings and protracted withdrawal symptoms	Emerging evidence; useful adjunct particularly for sleep and anxiety in early recovery
Topiramate	Reduces glutamate activity, enhances GABA	Off-label; reduces heavy drinking; evidence supports use
Baclofen	GABA-B agonist	Particularly used in patients with hepatic cirrhosis (not metabolized by liver); reduces craving

8.4 Psychosocial / Non-Pharmacological Management

Intervention	Rationale
Brief Intervention (BI) - 5-15 min motivational counseling in primary care	Evidence-based; reduces hazardous drinking in non-dependent patients; FRAMES model (Feedback, Responsibility, Advice, Menu, Empathy, Self-efficacy)
Motivational Interviewing (MI)	Elicits intrinsic motivation for change; patient-centered; avoids confrontation; increases treatment engagement
Cognitive Behavioral Therapy (CBT)	Addresses maladaptive thought patterns, identifies triggers, develops coping skills; most evidence-supported psychotherapy for AUD
Twelve-Step Programs (AA, NA)	Peer support; social network; accountability; spiritual framework; widely accessible
SMART Recovery	Secular, evidence-based alternative to 12-step; cognitive and behavioral tools
Contingency Management	Rewards abstinence with tangible incentives; most studied in stimulant use but applicable to AUD
Family Therapy	Addresses family system dysfunction, communication patterns; addresses enabling behaviors
Residential / Inpatient Rehabilitation	Indicated for severe AUD, multiple failed outpatient attempts, unsafe home environment, or complex comorbidities

9. COMPLICATIONS OF CHRONIC ALCOHOLISM

System	Complication	Mechanism
Neurological	Wernicke's encephalopathy (confusion, ophthalmoplegia, ataxia) → Korsakoff syndrome (amnesia, confabulation)	Thiamine deficiency
Neurological	Peripheral neuropathy	Direct neurotoxicity; B-vitamin deficiency
Neurological	Cerebellar degeneration	Direct neurotoxicity
Hepatic	Fatty liver → alcoholic hepatitis → cirrhosis → hepatocellular carcinoma	Direct ethanol toxicity; free radical formation; acetaldehyde toxicity
Pancreatic	Acute and chronic pancreatitis	Risk 4x general population
Cardiovascular	Dilated cardiomyopathy, atrial fibrillation, hypertension	Direct myocardial toxicity
Hematological	Macrocytic anemia, thrombocytopenia	Folate deficiency; direct bone marrow suppression
Oncological	Cancer of oral cavity, esophagus, larynx, liver, breast, colorectal	Synergistic with tobacco; acetaldehyde is a direct carcinogen
Endocrine	Hypoglycemia; gonadal dysfunction	Inhibition of gluconeogenesis; direct gonadal toxicity
Fetal	Fetal alcohol spectrum disorder (FASD)	Ethanol crosses placenta freely; teratogen with no safe dose in pregnancy
Immunological	Immunosuppression; increased infection risk	Impaired neutrophil and lymphocyte function

Sources: Goldman-Cecil Medicine (International Edition); Kaplan & Sadock's Synopsis of Psychiatry; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; The Washington Manual of Medical Therapeutics; DSM-5, American Psychiatric Association.

prevention

Finding Sources

Reading File

Excellent textbook content retrieved. Here is the comprehensive prevention guide:

Prevention of Substance Abuse / Alcoholism

Prevention operates across three levels - Primary (stop before it starts), Secondary (early detection and intervention), and Tertiary (prevent complications and relapse in those already affected).

LEVEL 1: PRIMARY PREVENTION

Goal: Prevent the onset of alcohol/substance use in at-risk individuals

Primary prevention targets the general population - especially youth, high-risk families, and communities - before harmful use begins.

1.1 Individual-Level Strategies

Strategy	Rationale
Health education and awareness programs	Providing accurate information about the short- and long-term consequences of alcohol on the brain, liver, heart, and relationships equips individuals to make informed choices. Ignorance of risk is a modifiable factor.
Life skills training	Teaching stress management, emotional regulation, problem-solving, refusal skills, and coping strategies reduces dependence on substances as external coping mechanisms.
Delay of drinking onset	The earlier a person begins drinking, the higher their risk of developing AUD. Each year of delayed initiation significantly reduces lifetime risk. Abstinence during brain development (before age 25) is the single most protective individual behavior.
Building self-esteem and resilience	Low self-esteem and maladaptive coping are independent risk factors for AUD. Programs building resilience, purpose, and social competence reduce vulnerability.
Identifying and treating comorbid mental illness early	Depression, anxiety, PTSD, and ADHD are strong predisposing factors - treating them early reduces self-medication with alcohol. Early psychiatric intervention is one of the most effective forms of primary prevention.

1.2 Family-Level Strategies

Strategy	Rationale
Parental education and modeling	Children of parents with AUD are 4-7 times more likely to develop AUD themselves. Teaching parents to model responsible behavior, set clear expectations, and maintain open communication about alcohol significantly reduces child risk.
Family-based prevention programs	Structured family programs (e.g., Strengthening Families Program) improve family bonding, communication, and discipline, all of which are protective against youth substance initiation.
Identifying and supporting children of parents with AUD	These children face both genetic predisposition and environmental exposure. Early identification allows targeted support, counseling, and education before harm begins.
Reducing adverse childhood experiences (ACEs)	Childhood abuse, neglect, or witnessing domestic violence dramatically raise AUD risk through HPA axis dysregulation. Family violence prevention, parenting support, and early childhood programs reduce ACE burden.

1.3 School-Based Strategies

Strategy	Rationale
School-based prevention curricula (e.g., DARE-enhanced, Life Skills Training, SBIRT in schools)	Evidence-based school programs that address social norms, peer pressure resistance, and decision-making reduce experimental use. Programs must be developmentally appropriate and delivered repeatedly, not as a single session.
Peer education programs	Adolescents are highly influenced by peer norms. Peer-led programs (where trained students deliver prevention messages) are more credible and effective than adult-led programs alone.
Creating safe, supportive school environments	Bullying, academic failure, school disconnection, and social isolation are all risk factors for substance use. Schools that foster belonging and achievement reduce substance initiation.
Sports, arts, and extracurricular engagement	Structured, supervised after-school activities reduce unsupervised time (a known risk period) and build protective factors like self-efficacy and pro-social bonds.

1.4 Community and Policy-Level Strategies

Strategy	Rationale
Minimum legal drinking age (MLDA) laws	Evidence consistently shows that higher MLDA laws reduce alcohol-related traffic fatalities and youth drinking initiation. The brain is not fully developed until ~25 years of age; legal protection during this period is strongly preventive.
Restricting alcohol advertising	Advertising exposure - especially via social media and during sporting events - is directly associated with earlier drinking onset and heavier consumption in youth. Restriction reduces normalization.
Alcohol pricing and taxation (minimum unit pricing)	Higher alcohol prices reduce consumption, especially among heavy drinkers and youth. A 10% increase in price reduces consumption by approximately 5-8%. This is one of the most cost-effective public health interventions available.
Limiting density of alcohol retail outlets	Areas with higher numbers of bars and liquor stores per capita consistently show higher rates of AUD, violence, and alcohol-related hospitalizations. Zoning restrictions reduce access and therefore use.
Responsible beverage service (RBS) training	Training bar and restaurant staff to refuse service to intoxicated customers and minors directly reduces acute harms (drunk driving, violence) and signals community norms around responsible drinking.
Reducing alcohol availability during COVID-type emergencies or crisis periods	Studies from multiple countries showed that when alcohol sales were restricted during lockdowns, alcohol-related hospitalizations dropped markedly, demonstrating the direct dose-response relationship between availability and harm.

LEVEL 2: SECONDARY PREVENTION

Goal: Early identification of at-risk or harmful drinking before full AUD develops

The target population here includes hazardous drinkers (those drinking above low-risk guidelines) who have not yet developed dependence.

2.1 Screening

All patients in primary care, emergency departments, and prenatal settings should be screened for AUD. The prevalence of problem drinking in general inpatient and outpatient medical settings is 15-40%, yet only ~20% of individuals with AUD ever receive treatment.

Screening Tool	Description	Threshold
AUDIT (Alcohol Use Disorders Identification Test)	10-item WHO questionnaire; gold standard	Score 8-15: hazardous; 16-19: harmful; ≥20: AUD
AUDIT-C	3-item rapid screen (quantity, frequency, binge)	≥3 (women), ≥4 (men): positive
CAGE	4 questions: Cut down, Annoyed, Guilty, Eye-opener	≥2 positive: warrants further assessment
SBIRT (Screening, Brief Intervention, Referral to Treatment)	Structured approach embedding screening into routine care	Framework adopted by SAMHSA; widely endorsed by medical organizations
Single-question screen	"How many times in the past year have you had X or more drinks in a day?" (X = 5 for men, 4 for women)	Any positive: sensitivity ~82% for unhealthy use

Screening rationale: Alcoholism is slow but progressive. Early identification - before end-organ damage, family destruction, or legal consequences - allows intervention at the most treatable stage. As with any chronic disorder, early detection changes the natural course of the disease.

2.2 Brief Intervention (BI)

Brief interventions (5-15 minutes) by a physician or nurse in primary care are among the most cost-effective medical interventions known. Harvard studies have ranked substance abuse interventions in the top 10% of all 587 life-saving medical interventions by cost-effectiveness.

Components of Effective Brief Intervention (FRAMES model):

Component	Content
F - Feedback	Share screening results and any abnormal labs (elevated GGT, MCV) in a non-judgmental, factual way: "Your liver enzymes suggest your liver is under stress from alcohol."
R - Responsibility	Emphasize that change is the patient's own choice and responsibility: "Only you can decide to change your drinking."
A - Advice	Provide clear, direct advice: "I strongly recommend you reduce your drinking to below low-risk guidelines."
M - Menu of options	Offer multiple pathways: cut down, abstain, refer to counseling, support groups - patient chooses.
E - Empathy	Use a warm, non-confrontational style. Avoid blame or lectures.
S - Self-efficacy	Express confidence in the patient's ability to change: "I believe you can do this."

2.3 Stages of Change - Targeting Interventions (Prochaska & DiClemente)

The family physician must first assess the patient's readiness to change before selecting an intervention strategy.

Stage	Patient's Position	Physician's Role
Pre-contemplation	Not aware of or denying the problem	Plant the seed. Share objective data (labs, vital signs). Offer written materials. Non-judgmental approach. Follow up regularly.
Contemplation	Aware a problem exists but not yet ready to act	Build urgency. Discuss consequences (GI bleeding, pancreatitis, family violence). Offer referral when ready. Short-interval follow-up.
Preparation	Planning to make a change soon	Assist in planning - identify barriers, choose a quit date, select a program.
Action	Actively making changes	Arrange detox (inpatient or outpatient). Refer to treatment program. Support and encourage.
Maintenance	Sustaining change, building new habits	Monitor labs (GGT, CDT, ETG urine). Review 12-step attendance. Screen for depression. Prescribe relapse prevention medications as indicated.
Relapse	Returned to use	Non-judgmental support. Re-enter treatment. Evaluate what triggered relapse. Reinforce that relapse is part of recovery, not failure.

LEVEL 3: TERTIARY PREVENTION

Goal: Prevent complications, disability, and relapse in patients already diagnosed with AUD

3.1 Pharmacological Relapse Prevention

Drug	Mechanism	Use in Relapse Prevention
Naltrexone (50 mg/day PO or monthly IM Vivitrol)	Blocks opioid receptors that mediate alcohol's reward; reduces the "buzz" and cravings	First-line; reduces heavy drinking days and time to relapse. IM formulation improves adherence.
Acamprosate (666 mg TID)	Modulates GABA/NMDA balance; reduces protracted withdrawal symptoms (insomnia, anxiety, dysphoria that drive relapse)	Best started after detox is complete; safe in liver disease; reduces relapse risk especially in patients with severe withdrawal anxiety
Gabapentin (300-600 mg TID, up to 1800 mg/day)	GABA analog; reduces craving, insomnia, and anxiety in early recovery	Particularly useful for the protracted withdrawal syndrome; evidence supports use in first 12 weeks of recovery
Topiramate (25-300 mg/day, titrated slowly)	Reduces glutamate activity; enhances GABA	Two large RCTs show significant reduction in heavy drinking days; well-tolerated; off-label
Carbamazepine / Valproate	Mood stabilizer; anticonvulsant	Evidence supports relapse prevention especially in patients with comorbid bipolar disorder and AUD; divalproex reduces return to heavy drinking vs. placebo (37% vs. 63%)
Baclofen	GABA-B receptor agonist	Useful in patients with hepatic cirrhosis (not liver-metabolized); reduces craving

3.2 Psychosocial Relapse Prevention

Intervention	Mechanism / Evidence
Cognitive Behavioral Therapy (CBT)	Identifies automatic thoughts that trigger drinking, teaches coping strategies, and builds relapse prevention skills. CBT helps patients identify high-risk situations and rehearse responses before re-exposure.
Motivational Enhancement Therapy (MET)	Builds and sustains motivation for continued sobriety; addresses ambivalence; particularly effective for patients with low treatment motivation.
12-Step Facilitation (AA/NA)	Peer support, accountability, sponsor relationship, and structured daily practices. AA has decades of evidence for sustained abstinence. Attendance frequency correlates with outcomes.
SMART Recovery	Secular evidence-based alternative; uses CBT and rational-emotive tools; online meetings available.
Contingency Management	Tangible rewards for verified abstinence (urine ETG monitoring + vouchers); especially effective in structured outpatient programs.
Mindfulness-Based Relapse Prevention (MBRP)	Combines mindfulness meditation with relapse prevention strategies; reduces automatic reactivity to craving cues.
Family therapy and support	Addresses enabling behaviors, communication patterns, and co-dependency that maintain the substance use environment. Al-Anon/Nar-Anon for family members.

3.3 Identifying and Managing High-Risk Situations (Relapse Triggers)

A core component of tertiary prevention is teaching patients to recognize and cope with their personal relapse triggers:

Trigger Category	Examples	Prevention Strategy
Emotional (HALT)	Hunger, Anger, Loneliness, Tiredness	HALT check; emotional regulation skills; stress reduction plan
Environmental / Cue-based	Passing a bar, seeing friends who drink, smelling alcohol	Avoidance of high-risk environments early in recovery; urge-surfing techniques
Social pressure	Peer invitations to drink, social events	Assertive refusal skills; practicing "I don't drink" responses; bringing a sober companion
Negative affect	Depression, anxiety, grief	Treatment of co-occurring mental illness; therapy; medication
Positive affect	Celebrations, successes, euphoric recall of using	Planning ahead for celebrations; having a sober support present
Protracted withdrawal	Insomnia, dysphoria, anxiety in weeks 2-12 of recovery	Pharmacotherapy (gabapentin, acamprosate); reassurance that symptoms resolve

3.4 Monitoring in Recovery (Preventing Silent Relapse)

Tool	Rationale
Urine ethyl glucuronide (ETG)	Detects alcohol use up to 72-80 hours after last drink; more sensitive than serum BAC; used in outpatient monitoring programs
Serum CDT (carbohydrate-deficient transferrin)	Elevated with >4 drinks/day sustained; persists 2-4 weeks after relapse; useful for medium-term monitoring
GGT, AST, ALT	Trending labs allow early detection of resumed heavy drinking; GGT normalizes within 4-6 weeks of abstinence
Regular physician follow-up	As with diabetes or hypertension, AUD requires scheduled chronic disease management - not a single "cure." Regular check-ins reinforce accountability and allow medication adjustment.

3.5 Special Populations in Prevention

Population	Special Considerations
Pregnant women	No safe level of alcohol in pregnancy. Universal screening at all prenatal visits. Fetal alcohol spectrum disorder (FASD) is entirely preventable. Motivational counseling; medication as needed.
Adolescents	Earlier onset = worse prognosis. School-based programs, family involvement, and mental health treatment are most effective. Avoid medications with addiction potential.
Elderly	Altered pharmacokinetics; lower doses cause more harm; increased fall risk; depression often drives use. Screening tools may underestimate use.
Healthcare workers	High-risk occupation (stress, access, culture). Physician Health Programs (PHPs) provide confidential monitoring and treatment.
Comorbid psychiatric illness (Dual Diagnosis)	Treating the primary psychiatric disorder (depression, PTSD, anxiety) is itself a form of substance abuse prevention. Integrated dual-diagnosis treatment is superior to treating each disorder separately.

SUMMARY: THE THREE LEVELS AT A GLANCE

PRIMARY PREVENTION       SECONDARY PREVENTION        TERTIARY PREVENTION
(General Population)     (At-Risk / Hazardous        (Diagnosed AUD)
                          Drinkers)
─────────────────────    ──────────────────────────   ─────────────────────────────
• Education              • Screening (AUDIT, CAGE)    • Detoxification
• Life skills training   • Brief Intervention (BI)    • Pharmacotherapy
• Delay drinking onset   • SBIRT in primary care        (Naltrexone, Acamprosate)
• Minimum drinking age   • Stages of Change approach  • CBT / MET / 12-Step
• Restrict advertising   • Lab monitoring             • Family therapy
• Alcohol taxation         (GGT, MCV, CDT)            • Relapse trigger management
• Reduce availability    • Motivational Interviewing  • Recovery monitoring (ETG)
• Family programs        • Referral to treatment      • Chronic disease follow-up
• School-based programs  • Treat comorbid MH illness  • Special population care

Sources: Textbook of Family Medicine 9e; Goldman-Cecil Medicine (International Edition); Kaplan & Sadock's Comprehensive Textbook of Psychiatry; The Washington Manual of Medical Therapeutics.

role of nurses

Finding Sources

Reading File

I have sufficient textbook foundation and expert nursing knowledge to deliver a comprehensive, well-structured answer. Here it is:

Role of Nurses in Substance Abuse / Alcoholism Care

The nurse is the most consistently present member of the healthcare team in a patient's care journey. In substance abuse, the nurse occupies a uniquely powerful position - spending more time with patients than any other clinician, administering medications, monitoring withdrawal, building trust, providing education, and serving as the bridge between the patient and the rest of the multidisciplinary team.

The nursing role spans seven major domains:

1. ASSESSMENT ROLE

The nurse is often the first point of contact and the most thorough assessor of the patient's condition.

1.1 Comprehensive Nursing Assessment

Assessment Domain	What the Nurse Does	Rationale
History taking	Document substance type(s), amount, frequency, duration, route of use, last use, previous withdrawal episodes, prior treatment attempts	Establishes baseline and risk profile. Prior withdrawal episodes are the strongest predictor of severe current withdrawal.
Physical assessment	Vital signs, neurological exam, skin (track marks, jaundice), abdominal exam (hepatomegaly), cardiovascular (arrhythmias), nutritional status (BMI, muscle wasting)	Alcohol and drugs affect every organ system; comprehensive assessment identifies life-threatening complications early.
Mental status exam	Level of consciousness, orientation, affect, suicidal/homicidal ideation, hallucinations, delusions, memory	Co-occurring psychiatric disorders are extremely common in AUD; missed psychiatric comorbidity leads to treatment failure.
Suicide risk assessment	Columbia Suicide Severity Rating Scale (C-SSRS) on admission and each shift; history of prior attempts; current ideation	History of prior suicide attempt is the single strongest predictor of future attempt; substance use significantly elevates risk.
Withdrawal severity scoring	CIWA-Ar (alcohol), COWS (opioids), every 1-2 hours during acute phase	Standardized scoring guides medication titration, detects deterioration, and prevents both under- and over-treatment.
Social and family assessment	Living situation, social support, employment, legal history, family dynamics, presence of abuse or trauma	Social determinants of health are major drivers of both substance use and recovery success; discharge planning begins at admission.
Spiritual and cultural assessment	Beliefs about illness, recovery, and treatment; cultural attitudes toward help-seeking and stigma	Culturally competent care improves therapeutic engagement and treatment adherence.

2. CLINICAL / MONITORING ROLE

The nurse is the primary clinician responsible for moment-to-moment safety monitoring during the most dangerous phase of care - acute withdrawal.

2.1 Monitoring During Detoxification

Monitoring Task	Frequency	Rationale
Vital signs (BP, HR, RR, Temp, SpO2)	Every 1-2 hours during acute withdrawal; every 4 hours once stabilized	Tachycardia, hypertension, and fever are early signs of autonomic hyperactivity; detection allows timely pharmacological intervention before delirium tremens develops.
CIWA-Ar scoring	Every 1-2 hours (score ≥8); every 4 hours (score <8)	Guides symptom-triggered benzodiazepine dosing, which is superior to fixed-dose schedules in preventing over- or under-treatment.
Neurological status	Each assessment	Altered LOC, confusion, or new focal signs may indicate Wernicke's encephalopathy, seizure postictal state, or DTs onset.
Seizure surveillance	Continuous	Withdrawal seizures peak at 24-48 hours; nurse must recognize, time, protect airway, call for help, and document.
Fluid balance and hydration	Each shift	Diaphoresis, vomiting, and poor intake rapidly cause dehydration and electrolyte imbalances (low Mg, K, PO4) that lower the seizure threshold.
Lab value tracking	Per orders; alert physician for critical values	GGT, LFTs, electrolytes, CBC, blood glucose - abnormalities require prompt action. Hypoglycemia is a common, dangerous, underrecognized complication.
Pain and comfort assessment	Each shift	Untreated discomfort drives early self-discharge against medical advice (AMA).

2.2 Medication Administration and Safety

Nursing Action	Rationale
Administer thiamine IV/IM before any dextrose	Prevents Wernicke's encephalopathy - a catastrophic and irreversible neurological complication of thiamine deficiency precipitated by glucose loading.
Administer benzodiazepines per CIWA-Ar protocol (symptom-triggered)	Treats withdrawal safely with the minimum effective dose; reduces risk of excessive sedation and respiratory depression.
Assess sedation level before and after each benzodiazepine dose	Benzodiazepines can cause respiratory depression especially with polysubstance use (e.g., opioids + alcohol).
Monitor for paradoxical agitation with benzodiazepines	Elderly patients and patients with encephalopathy can become paradoxically agitated with benzodiazepines; nurse must recognize and report this.
Administer naltrexone, acamprosate, or other relapse prevention medications as ordered; educate patient on purpose and side effects	Patients who understand why they are taking a medication are significantly more adherent.

3. THERAPEUTIC RELATIONSHIP ROLE

This is the most uniquely nursing role - one that no other team member can replicate in the same way.

3.1 Building a Therapeutic Alliance

Principle	Application
Non-judgmental attitude	Use neutral, factual language. Avoid terms like "addict," "drunk," or "junkie." Use person-first language: "a person with alcohol use disorder." The nurse's attitude profoundly shapes whether the patient engages with or withdraws from care.
Unconditional positive regard	Accept the patient as a person of worth regardless of their behavior or history. This Rogerian principle is foundational to any therapeutic relationship in psychiatry and addiction nursing.
Empathy, not sympathy	Acknowledge and validate feelings ("It sounds like you've been carrying enormous shame about this") without minimizing them or becoming emotionally swept up in them.
Consistency and reliability	Follow through on promises - if you say you will return at 2 PM, return at 2 PM. Trust is built in small, repeated acts of reliability. Patients with addiction histories often have deep distrust of authority and institutions.
Appropriate boundaries	The nurse maintains a professional relationship - warm but boundaried. Over-involvement (rescuing, taking sides, sharing personal struggles) is harmful and constitutes a boundary violation.
Honest, direct communication	Do not collude with denial. When the patient minimizes their use, the nurse reflects objective findings: "Your liver enzymes and tremors tell me your body is under real stress from alcohol."

3.2 Motivational Interviewing (MI) Techniques

Nurses trained in MI use these evidence-based communication strategies in every patient interaction:

MI Skill	Example
Open-ended questions	"Tell me what a typical day looks like for you." / "What concerns you most about your health right now?"
Affirmations	"It took courage to come in today." / "You've dealt with a lot and you're still here."
Reflective listening	Patient: "I don't really have a problem." Nurse: "You're not sure if alcohol is something to be worried about." (reflect without arguing)
Summarizing	Periodically summarize what the patient has said to show you are listening and to allow them to correct misunderstandings.
Developing discrepancy	"You mentioned your children are the most important thing to you. How does your drinking affect your relationship with them?"
Rolling with resistance	Instead of confronting denial, the nurse sidesteps it: "You might be right that it's not as serious as I'm suggesting. What would it take for you to consider it a problem?"

4. HEALTH EDUCATION ROLE

The nurse is the primary patient educator in the inpatient and outpatient setting.

4.1 Key Teaching Areas

Topic	Content	Teaching Method
Disease model of addiction	Addiction is a chronic brain disease involving neurochemical changes in GABA, glutamate, and dopamine systems - not a moral failure or weakness.	Verbal + written; use analogies (diabetes, hypertension) to reduce stigma.
Withdrawal process	What to expect: tremors, sweating, anxiety, possible seizures; timeline; why medications are given; importance of not stopping medications abruptly.	One-on-one; time teaching when patient is alert and not in acute distress.
Medications	What each medication does (naltrexone blocks reward; acamprosate reduces cravings; thiamine protects the brain), expected side effects, how to take them.	Teach-back method - ask patient to explain it back in their own words.
Nutrition	Importance of regular meals; foods rich in B-vitamins, protein, and complex carbohydrates; avoidance of caffeine and sugar in early recovery.	Dietary handouts; involve dietitian for reinforcement.
Relapse warning signs	HALT (Hunger, Anger, Loneliness, Tiredness); environmental triggers; craving management techniques; what to do if they relapse.	Role-play; scenario-based teaching.
Community resources	AA/NA meeting schedules, SMART Recovery, SAMHSA Helpline (1-800-662-4357), outpatient programs, crisis lines.	Written resource list; assist with connecting before discharge.
Family education	Addiction as a family disease; enabling vs. supporting; Al-Anon/Nar-Anon; setting healthy boundaries with consent of patient.	Family meeting; written materials.

4.2 Principles of Effective Teaching in Addiction Nursing

Assess readiness to learn before beginning - teaching during acute withdrawal will not be retained
Use plain language at no higher than a 6th-grade reading level
Use teach-back ("Can you tell me in your own words why we gave you thiamine before the IV drip?")
Repeat key messages across multiple interactions - a single teaching session is rarely sufficient
Be culturally sensitive - adapt content and approach to the patient's cultural background, beliefs, and literacy level

5. ADVOCACY ROLE

5.1 Advocating for the Patient

Advocacy Action	Rationale
Challenge stigma within the care team	Nurses must actively address stigmatizing language or attitudes from colleagues ("Why are we wasting a bed on him again?"). Stigma within healthcare is a documented barrier to quality AUD care.
Ensure informed consent	Patients have the right to understand and agree to their treatment, including medications for withdrawal and relapse prevention.
Respect patient autonomy	The nurse supports the patient's right to make decisions about their own treatment, including the goal of harm reduction rather than full abstinence when that is the patient's choice.
Advocate for psychiatric co-management	Nurses who identify suicidal ideation, psychosis, or severe depression advocate strongly for psychiatric consultation.
Advocate for social services	Connect patients with social work for housing, food security, employment, legal aid, and child services - all of which impact recovery outcomes.
Protect confidentiality	Substance use disorder treatment records carry additional legal protection under 42 CFR Part 2 in the USA. Nurses must understand and protect these rights.

6. COORDINATION AND COLLABORATION ROLE

The nurse serves as the hub of the multidisciplinary team in substance abuse care.

6.1 Multidisciplinary Team Coordination

Team Member	Nurse's Coordinating Role
Physician / Prescriber	Report CIWA-Ar scores, vital sign trends, and response to medications; flag deterioration; ensure orders are complete and appropriate.
Psychiatrist	Communicate mental status findings, suicidality assessment, and response to psychiatric medications; facilitate psychiatric evaluations.
Social Worker	Share information about housing instability, family dynamics, financial stressors; coordinate discharge planning and community referrals.
Registered Dietitian	Refer for nutritional assessment; reinforce dietary teaching; communicate concerns about refeeding or ongoing nausea/vomiting.
Addiction Counselor	Facilitate access to counseling sessions; provide behavioral updates; reinforce counseling themes in day-to-day nursing interactions.
Pharmacist	Clarify medication dosing, drug interactions (e.g., benzodiazepines in liver disease), and patient education on medications.
Family / Support System	With patient consent, provide education, involve in discharge planning, and connect to Al-Anon/Nar-Anon.

6.2 Discharge Planning (Begins at Admission)

Discharge Planning Task	Nurse's Role
Assess home environment and support system	Identifies safety risks and informs level of care at discharge
Ensure prescriptions are ready	Naltrexone, acamprosate, thiamine, vitamins, psychiatric medications
Confirm follow-up appointments are booked	Primary care within 2 weeks; psychiatry within 1 week; addiction counselor
Provide written discharge instructions in plain language	Patient takes a clear, actionable plan home
Warm handoff to community programs	Phone call to outpatient program or sponsoring AA member before discharge
Safety plan documented and given to patient	Written copy of safety plan including crisis contacts, emergency numbers

7. SELF-CARE AND PROFESSIONAL ROLE

Working with patients with substance use disorders is emotionally demanding. Nurses must maintain their own well-being to provide effective, compassionate care.

7.1 Managing Compassion Fatigue and Burnout

Challenge	Strategy
Moral distress (watching repeated readmissions, relapses)	Reframe relapse as part of the chronic disease process - not failure of the nurse or the patient.
Secondary trauma	Regular clinical supervision, debriefing after difficult cases.
Countertransference	Self-awareness about personal feelings toward patients (frustration, over-identification, rescue urges). Clinical supervision and peer support help maintain objectivity.
Boundary maintenance	Clear professional boundaries protect both nurse and patient; blurred boundaries lead to burnout and harm.
Personal substance use history	Nurses with their own recovery history must be particularly mindful of countertransference and ensure their own recovery supports are in place.

7.2 Continuing Professional Development

Area	Importance
Addiction nursing certification (CARN - Certified Addictions Registered Nurse)	Validates specialized knowledge and skills; improves patient outcomes
Motivational Interviewing training	An evidence-based skill that significantly improves patient engagement and treatment entry
Mental health first aid / suicide prevention training	AUD has 2-3x elevated suicide risk; nurses must be trained and confident in assessment and intervention
Cultural competency training	Substance use and recovery norms vary significantly across cultures; culturally informed care is more effective
Trauma-informed care training	The majority of patients with AUD have a trauma history; trauma-informed approaches improve safety, engagement, and outcomes

SUMMARY: THE NURSE'S ROLES AT A GLANCE

┌─────────────────────────────────────────────────────────────┐
│                   ROLES OF THE NURSE IN                     │
│               SUBSTANCE ABUSE / ALCOHOLISM CARE             │
├──────────────────────┬──────────────────────────────────────┤
│ 1. ASSESSOR          │ Comprehensive physical, mental,       │
│                      │ social, and risk assessment           │
├──────────────────────┼──────────────────────────────────────┤
│ 2. MONITOR /         │ CIWA-Ar scoring, vital signs,         │
│    CLINICIAN         │ medication administration, safety     │
├──────────────────────┼──────────────────────────────────────┤
│ 3. THERAPEUTIC       │ Building trust, motivational          │
│    RELATIONSHIP      │ interviewing, empathy, boundaries     │
├──────────────────────┼──────────────────────────────────────┤
│ 4. EDUCATOR          │ Disease model, medications, nutrition,│
│                      │ relapse prevention, resources         │
├──────────────────────┼──────────────────────────────────────┤
│ 5. ADVOCATE          │ Anti-stigma, patient rights,          │
│                      │ confidentiality, social services      │
├──────────────────────┼──────────────────────────────────────┤
│ 6. COORDINATOR       │ Multidisciplinary team hub,           │
│                      │ discharge planning, warm handoffs     │
├──────────────────────┼──────────────────────────────────────┤
│ 7. SELF-CARE /       │ Preventing burnout, professional      │
│    PROFESSIONAL      │ development, trauma-informed care     │
└──────────────────────┴──────────────────────────────────────┘

The nurse does not simply administer medications or chart observations. In substance abuse care, the nurse is often the patient's most trusted contact - the person who checks on them at 3 AM during a terrifying withdrawal, the one who first hears "I think I'm ready to get help," and the one who hands them a resource list and says "You can do this." That therapeutic presence, grounded in clinical expertise, is irreplaceable.

Sources: Textbook of Family Medicine 9e; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Goldman-Cecil Medicine; The Washington Manual of Medical Therapeutics - all accessed via the medical textbook library.

nursing care plan for alcoholism

Finding Sources

Reading File

Finding Sources

Reading File

Excellent clinical data retrieved. Now delivering the full, detailed nursing care plan:

NANDA Nursing Care Plan: Alcoholism (Alcohol Use Disorder)

PATIENT SCENARIO

Patient: 48-year-old male, admitted to the medical unit after his wife found him confused, trembling, and unable to stand. He drinks approximately 8-10 standard drinks daily for the past 6 years. His last drink was 14 hours ago. Medical history includes hypertension, fatty liver disease, and one prior hospitalization for alcohol withdrawal 2 years ago.

ASSESSMENT

Subjective Data (What the Patient Reports)

"My hands won't stop shaking."
"I feel like bugs are crawling on my skin."
"I'm sweating even though I'm cold."
"I hear things that aren't there - voices."
"I haven't eaten properly in days, no appetite."
"I tried to quit before but always go back - I can't do it."
"My wife is threatening to leave me. I've lost everything."
"I know I need help but I'm scared of the withdrawal."
"My stomach hurts and I keep feeling sick."
"I can't remember things - my memory is getting bad."

Objective Data (What the Nurse Observes / Measures)

BP: 162/98 mmHg | HR: 116 bpm | RR: 22/min | Temp: 38.1°C | SpO2: 95% RA
CIWA-Ar score: 22 (severe withdrawal - pharmacotherapy required)
Coarse bilateral hand tremors, hyperreflexia
Diaphoresis, flushed face, dilated pupils (mydriasis)
Nausea with one episode of vomiting since admission
Disoriented to time; oriented to person and place
Reports visual and auditory hallucinations (insects, voices)
GCS: 13
Weight: 59 kg; BMI: 18.1 (underweight); muscle wasting visible
Labs: Na 132 mEq/L (low), K 3.1 mEq/L (low), Mg 1.4 mg/dL (low), Glucose 62 mg/dL (low)
AST 112 U/L, ALT 58 U/L (AST:ALT ratio >2:1 - consistent with alcoholic liver disease)
GGT: 189 U/L (markedly elevated)
Hemoglobin: 10.1 g/dL; MCV: 104 fL (macrocytic anemia)
Albumin: 2.6 g/dL (low)
Urine EtG: positive; Urine tox screen: alcohol only
Skin: dry mucous membranes, poor turgor; jaundiced sclera noted
Track marks absent (no IV drug use)
Affect: anxious, agitated; poor eye contact; easily startled
PHQ-2 screening: positive (possible depression)
History of prior withdrawal episode with seizure 2 years ago

NURSING DIAGNOSES, GOALS, INTERVENTIONS, RATIONALE, AND EVALUATION

NURSING DIAGNOSIS #1 - PRIORITY: HIGHEST

Risk for Injury related to CNS hyperexcitability, electrolyte imbalances, and altered mental status secondary to severe alcohol withdrawal as evidenced by CIWA-Ar score of 22, bilateral tremors, history of prior withdrawal seizure, hypoglycemia, hypomagnesemia, hypokalemia, and auditory/visual hallucinations.

Goal / Expected Outcome: Patient will remain free from injury (seizures, falls, aspiration, self-harm) throughout hospitalization. CIWA-Ar score will decrease to below 10 within 48-72 hours. Vital signs will trend toward normal (BP <140/90 mmHg, HR <100 bpm) within 24-48 hours.